Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension

被引:1
|
作者
Zhang, Chang [1 ]
Tsang, Yuen [2 ]
He, Jinghua [3 ]
Panjabi, Sumeet [2 ]
机构
[1] Janssen Business Technol Commercial Data Sci, Titusville, NJ USA
[2] Janssen Sci Affairs LLC, Real World Value & Evidence, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA
[3] Janssen Sci Affairs LLC, Real World Res, Titusville, NJ USA
关键词
Hospitalization; Healthcare resource utilization; Predictive risk factors; Patient characteristics; Pulmonary arterial hypertension; SCORE CALCULATOR; SURVIVAL; REGISTRY; MANAGEMENT; OUTCOMES; COSTS;
D O I
10.1007/s12325-023-02501-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionUS claims-based analyses emphasize the substantial hospitalization burden of patients with pulmonary arterial hypertension (PAH) and the significant need for improved monitoring and more timely interventions. A claims-based predictive model may be useful to assist healthcare providers and payers in identifying patients with PAH at increased hospitalization risk. To address this aim, we constructed statistical models using baseline patient variables available in administrative healthcare claims to predict patients' risk for all-cause and PH-related hospitalization within 1 year of initiating >= 1 PAH indicated medication.MethodsAdult patients with PAH who newly initiated >= 1 PAH indicated medication were selected from the MarketScan Commercial and Medicare Supplemental databases (January 1, 2009-January 31, 2019). Cox regression models were built with a randomly selected training set and evaluated using a validation set of remaining patients. Predictive variables for the models were selected in three steps: clinical knowledge, univariate analysis, and backward stepwise selection.ResultsWithin 1 year of initiating >= 1 PAH indicated medication, 1502/3872 (38.8%) had an all-cause hospitalization and 950/3872 (24.5%) had a pulmonary hypertension (PH)-related hospitalization. Predictive risk factors for all-cause hospitalization were Quan-Charlson Comorbidity Index (CCI) score 2-3 [hazard ratio (HR) 1.229; P = 0.038] and >= 4 (HR 1.531; P < 0.001), claims-based frailty index (CFI) score > 1 (highest frailty level; HR 1.301; P = 0.018), hemoptysis (HR 1.254; P = 0.016), malaise/fatigue (HR 1.150; P = 0.037), history of PH-related hospitalization (HR 1.171; P = 0.011), non-PH-related ER visit (HR 1.713; P = 0.014), and higher non-PH-related outpatient visit cost (HR 1.069; P < 0.001). Predictive risk factors for PH-related hospitalization were female sex (HR 1.264; P = 0.004), Quan-CCI score >= 4 (HR 1.408; P = 0.008), portal hypertension (HR 1.565; P = 0.019), CFI score > 1 (HR 1.522; P = 0.002), dyspnea (HR 1.259; P = 0.023), and history of PH-related hospitalization (HR 1.273; P = 0.002).ConclusionsThe US claims-based predictive models showed acceptable performance to predict 1-year hospitalization among patients with PAH.
引用
收藏
页码:2481 / 2492
页数:12
相关论文
共 50 条
  • [21] Predicting survival in pulmonary arterial hypertension in the UK
    Lee, Wai-Ting Nicola
    Ling, Yi
    Sheares, Karen K.
    Pepke-Zaba, Joanna
    Peacock, Andrew John
    Johnson, Martin Keith
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (03) : 604 - 611
  • [22] Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies
    Benza, Raymond L.
    Gomberg-Maitland, Mardi
    Elliott, C. Greg
    Farber, Harrison W.
    Foreman, Aimee J.
    Frost, Adaani E.
    McGoon, Michael D.
    Pasta, David J.
    Selej, Mona
    Burger, Charles D.
    Frantz, Robert P.
    CHEST, 2019, 156 (02) : 323 - 337
  • [23] Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
    Vraka, Argyro
    Diamanti, Eleni
    Kularatne, Mithum
    Yerly, Patrick
    Lador, Frederic
    Aubert, John-David
    Lechartier, Benoit
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [24] Imaging risk in pulmonary arterial hypertension
    Badagliacca, Roberto
    Vizza, Carmine Dario
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (03)
  • [25] Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension
    Jing, Zhi-Cheng
    Strange, Geoff
    Zhu, Xian-Yang
    Zhou, Da-Xin
    Shen, Jie-Yan
    Gu, Hong
    Yang, Zhen-Kun
    Pan, Xin
    Xiang, Mei-Xiang
    Yao, Hua
    Zhao, Dong-Bao
    Dalton, Brad S.
    Zhang, Zhuo-Li
    Wang, Yong
    Cheng, Xian-Sheng
    Yang, Yue-Jin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02) : 150 - 156
  • [26] The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension
    Kanwar, Manreet
    Raina, Amresh
    Lohmueller, Lisa
    Kraisangka, Jidapa
    Benza, Raymond
    CURRENT HYPERTENSION REPORTS, 2019, 21 (06)
  • [27] The study of risk in pulmonary arterial hypertension
    Rubin, Lewis J.
    Simonneau, Gerald
    Badesch, David
    Galie, Nazzareno
    Humbert, Marc
    Keogh, Anne
    Massaroe, Joseph
    Cerinic, Marco Matucci
    Sitbon, Olivier
    Kymes, Steven
    EUROPEAN RESPIRATORY REVIEW, 2012, 21 (125) : 234 - 238
  • [28] Risk Factors for Predicting Mortality among Old Patients with Acute Myocardial Infarction during Hospitalization
    Chen, Liwei
    Han, Ling
    Luo, Jingguang
    HEART SURGERY FORUM, 2019, 22 (02) : E165 - E169
  • [29] Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
    Yamagata, Yuki
    Ikeda, Satoshi
    Kojima, Sanae
    Ueno, Yuki
    Nakata, Tomoo
    Koga, Seiji
    Ohno, Chikara
    Yonekura, Tsuyoshi
    Yoshimuta, Tsuyoshi
    Minami, Takako
    Kawano, Hiroaki
    Maemura, Koji
    CIRCULATION JOURNAL, 2022, 86 (06) : 936 - +
  • [30] Predicting 1-year mortality after hospitalization for community-acquired pneumonia
    Uranga, Ane
    Quintana, Jose M.
    Aguirre, Urko
    Artaraz, Amaia
    Diez, Rosa
    Pascual, Silvia
    Ballaz, Aitor
    Espana, Pedro P.
    PLOS ONE, 2018, 13 (02):